EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin

Muhammad Usman Shams, Abdul Hannan Nagi, Saqib Mehmood, Nausheen Henna

Journal of the Pakistan Medical Association · 20.04.2026 · 76 (05) · 662-666

DOI: 10.47391/jpma.22072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pakistan Medical Association, online erschienen am 20.04.2026. Verfasst von Muhammad Usman Shams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology and Lab Management, University of Health Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Skin Neoplasms, Cutaneous Squamous Cell Carcinoma, Carcinoma, Squamous Cell. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the frequency and level of expression of enhancer of zeste homologue 2 in cutaneous squamous cell carcinoma, and compare then with normal skin.

Method

The retrospective, descriptive study was conducted at the Department of Morbid Anatomy and Histopathology, University of Health Sciences, Lahore, Pakistan, and comprised data from January 2016 to April 2023 related to cutaneous squamous cell carcinoma in group A and normal skin cases in group B that were evaluated and compared for enhancer of zeste homologue 2 immunohistochemistry expression and positivity. Group A cases with increased immunohistochemistry expression were tested by fluorescence in situ hybridisation for enhancer of zeste homologue 2 amplification. Data was analysed using SPSS 22.

Results

Of the 60 patients, 30(50%) were in group A; 19(63.3%) males and 11(36.7%) females with mean age 48±16.5 years. There were 30(50%) patients in group B; 29(96.7%) females and 1(0.3%) male with mean age 47.6±11.3 years. There were 25(83.3%) well-differentiated cases in group A. Enhancer of zeste homologue 2 positivity was noted in 25(83.3%) case in group A compared to 6(20%) in group B (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinSkin NeoplasmsCutaneous Squamous Cell CarcinomaCarcinoma, Squamous CellHumansFemaleMaleMiddle AgedRetrospective StudiesImmunohistochemistryAdultBiomarkers, TumorIn Situ Hybridization, FluorescenceAgedEpigenesis, Genetic

Stichwörter der Autor:innen

EZH2 protein, Human, Immunohistochemistry, IHC, In situ hybridisation, Fluoresc…

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Histopathology and Lab Management, University of Health Sciences, Lahore, Pakistan.
  • University of Health Sciences, Lahore, Pakistan.

Zitieren

APA

Shams, M. U., Nagi, A. H., Mehmood, S., & Henna, N. (2026). Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin. Journal of the Pakistan Medical Association, 76(05), 662-666. https://doi.org/10.47391/jpma.22072

Vancouver

Shams MU, Nagi AH, Mehmood S, Henna N. Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin. Journal of the Pakistan Medical Association. 2026;76(05):662-666. doi:10.47391/jpma.22072

BibTeX
@article{Shams2026,
  author = {Shams, Muhammad Usman and Nagi, Abdul Hannan and Mehmood, Saqib and Henna, Nausheen},
  title = {Expression of epigenetic marker EZH2 in squamous cell carcinoma of skin},
  journal = {Journal of the Pakistan Medical Association},
  year = {2026},
  volume = {76},
  number = {05},
  pages = {662--666},
  doi = {10.47391/jpma.22072}
}
Kostenlos starten →